nodes	percent_of_prediction	percent_of_DWPC	metapath
Pergolide—HTR2A—chronic obstructive pulmonary disease	0.397	1	CbGaD
Pergolide—CYP2D6—Formoterol—chronic obstructive pulmonary disease	0.0364	0.17	CbGbCtD
Pergolide—CYP2D6—Arformoterol—chronic obstructive pulmonary disease	0.0364	0.17	CbGbCtD
Pergolide—CYP2D6—Tiotropium—chronic obstructive pulmonary disease	0.0324	0.152	CbGbCtD
Pergolide—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.0305	0.143	CbGbCtD
Pergolide—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.0206	0.0966	CbGbCtD
Pergolide—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.0197	0.0921	CbGbCtD
Pergolide—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.0175	0.0821	CbGbCtD
Pergolide—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.0103	0.0482	CbGbCtD
Pergolide—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.00971	0.0455	CbGbCtD
Pergolide—HTR2A—phrenic nerve—chronic obstructive pulmonary disease	0.00456	0.415	CbGeAlD
Pergolide—Cabergoline—ADRB2—chronic obstructive pulmonary disease	0.00172	0.349	CrCbGaD
Pergolide—HTR2A—pulmonary artery—chronic obstructive pulmonary disease	0.00166	0.151	CbGeAlD
Pergolide—Methylergometrine—HTR2A—chronic obstructive pulmonary disease	0.0012	0.244	CrCbGaD
Pergolide—Cabergoline—HTR2A—chronic obstructive pulmonary disease	0.0012	0.244	CrCbGaD
Pergolide—Lisuride—HTR2A—chronic obstructive pulmonary disease	0.000804	0.163	CrCbGaD
Pergolide—HTR1D—connective tissue—chronic obstructive pulmonary disease	0.000494	0.0449	CbGeAlD
Pergolide—DRD2—respiratory system—chronic obstructive pulmonary disease	0.000422	0.0384	CbGeAlD
Pergolide—HTR2B—smooth muscle tissue—chronic obstructive pulmonary disease	0.00042	0.0382	CbGeAlD
Pergolide—ADRA2C—bronchus—chronic obstructive pulmonary disease	0.000338	0.0307	CbGeAlD
Pergolide—ADRA2C—trachea—chronic obstructive pulmonary disease	0.000303	0.0276	CbGeAlD
Pergolide—ADRA2A—connective tissue—chronic obstructive pulmonary disease	0.000288	0.0262	CbGeAlD
Pergolide—HTR2A—respiratory system—chronic obstructive pulmonary disease	0.000278	0.0253	CbGeAlD
Pergolide—HTR2B—lung—chronic obstructive pulmonary disease	0.000277	0.0252	CbGeAlD
Pergolide—ADRA2A—bronchus—chronic obstructive pulmonary disease	0.00027	0.0245	CbGeAlD
Pergolide—HTR2A—connective tissue—chronic obstructive pulmonary disease	0.000245	0.0223	CbGeAlD
Pergolide—ADRA2A—trachea—chronic obstructive pulmonary disease	0.000242	0.022	CbGeAlD
Pergolide—Arthralgia—Formoterol—chronic obstructive pulmonary disease	0.000236	0.000897	CcSEcCtD
Pergolide—Chest pain—Arformoterol—chronic obstructive pulmonary disease	0.000236	0.000897	CcSEcCtD
Pergolide—Myalgia—Formoterol—chronic obstructive pulmonary disease	0.000236	0.000897	CcSEcCtD
Pergolide—Myalgia—Arformoterol—chronic obstructive pulmonary disease	0.000236	0.000897	CcSEcCtD
Pergolide—Arthralgia—Arformoterol—chronic obstructive pulmonary disease	0.000236	0.000897	CcSEcCtD
Pergolide—Convulsion—Montelukast—chronic obstructive pulmonary disease	0.000236	0.000894	CcSEcCtD
Pergolide—Anxiety—Formoterol—chronic obstructive pulmonary disease	0.000236	0.000894	CcSEcCtD
Pergolide—Anxiety—Arformoterol—chronic obstructive pulmonary disease	0.000236	0.000894	CcSEcCtD
Pergolide—Vertigo—Salbutamol—chronic obstructive pulmonary disease	0.000236	0.000894	CcSEcCtD
Pergolide—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.000235	0.000893	CcSEcCtD
Pergolide—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.000235	0.000893	CcSEcCtD
Pergolide—Syncope—Salbutamol—chronic obstructive pulmonary disease	0.000235	0.000892	CcSEcCtD
Pergolide—Neuropathy—Prednisone—chronic obstructive pulmonary disease	0.000235	0.00089	CcSEcCtD
Pergolide—Discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000234	0.000886	CcSEcCtD
Pergolide—Discomfort—Formoterol—chronic obstructive pulmonary disease	0.000234	0.000886	CcSEcCtD
Pergolide—Palpitations—Salbutamol—chronic obstructive pulmonary disease	0.000232	0.000879	CcSEcCtD
Pergolide—Arthralgia—Montelukast—chronic obstructive pulmonary disease	0.000232	0.000878	CcSEcCtD
Pergolide—Myalgia—Montelukast—chronic obstructive pulmonary disease	0.000232	0.000878	CcSEcCtD
Pergolide—Dry mouth—Arformoterol—chronic obstructive pulmonary disease	0.000231	0.000877	CcSEcCtD
Pergolide—Dry mouth—Formoterol—chronic obstructive pulmonary disease	0.000231	0.000877	CcSEcCtD
Pergolide—Anxiety—Montelukast—chronic obstructive pulmonary disease	0.000231	0.000875	CcSEcCtD
Pergolide—Loss of consciousness—Salbutamol—chronic obstructive pulmonary disease	0.00023	0.000874	CcSEcCtD
Pergolide—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.00023	0.000871	CcSEcCtD
Pergolide—Dry skin—Prednisolone—chronic obstructive pulmonary disease	0.000229	0.000868	CcSEcCtD
Pergolide—Cough—Salbutamol—chronic obstructive pulmonary disease	0.000229	0.000868	CcSEcCtD
Pergolide—Oesophagitis—Prednisone—chronic obstructive pulmonary disease	0.000228	0.000866	CcSEcCtD
Pergolide—Oedema—Arformoterol—chronic obstructive pulmonary disease	0.000227	0.00086	CcSEcCtD
Pergolide—Oedema—Formoterol—chronic obstructive pulmonary disease	0.000227	0.00086	CcSEcCtD
Pergolide—Hypertension—Salbutamol—chronic obstructive pulmonary disease	0.000226	0.000859	CcSEcCtD
Pergolide—Infection—Arformoterol—chronic obstructive pulmonary disease	0.000225	0.000854	CcSEcCtD
Pergolide—Infection—Formoterol—chronic obstructive pulmonary disease	0.000225	0.000854	CcSEcCtD
Pergolide—HTR2A—smooth muscle tissue—chronic obstructive pulmonary disease	0.000224	0.0204	CbGeAlD
Pergolide—DRD2—lung—chronic obstructive pulmonary disease	0.000224	0.0204	CbGeAlD
Pergolide—Arthralgia—Salbutamol—chronic obstructive pulmonary disease	0.000223	0.000847	CcSEcCtD
Pergolide—Chest pain—Salbutamol—chronic obstructive pulmonary disease	0.000223	0.000847	CcSEcCtD
Pergolide—Myalgia—Salbutamol—chronic obstructive pulmonary disease	0.000223	0.000847	CcSEcCtD
Pergolide—Pulmonary oedema—Prednisone—chronic obstructive pulmonary disease	0.000222	0.000844	CcSEcCtD
Pergolide—Anxiety—Salbutamol—chronic obstructive pulmonary disease	0.000222	0.000844	CcSEcCtD
Pergolide—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.000222	0.000842	CcSEcCtD
Pergolide—Oedema—Montelukast—chronic obstructive pulmonary disease	0.000222	0.000842	CcSEcCtD
Pergolide—Tachycardia—Formoterol—chronic obstructive pulmonary disease	0.000221	0.000839	CcSEcCtD
Pergolide—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	0.000221	0.000839	CcSEcCtD
Pergolide—Discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000221	0.000837	CcSEcCtD
Pergolide—Infection—Montelukast—chronic obstructive pulmonary disease	0.00022	0.000836	CcSEcCtD
Pergolide—Dry mouth—Salbutamol—chronic obstructive pulmonary disease	0.000218	0.000828	CcSEcCtD
Pergolide—Hyperkinesia—Prednisone—chronic obstructive pulmonary disease	0.000218	0.000827	CcSEcCtD
Pergolide—ADRA2C—lung—chronic obstructive pulmonary disease	0.000218	0.0198	CbGeAlD
Pergolide—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.000217	0.000824	CcSEcCtD
Pergolide—Abdominal distension—Prednisolone—chronic obstructive pulmonary disease	0.000217	0.000824	CcSEcCtD
Pergolide—Sepsis—Prednisone—chronic obstructive pulmonary disease	0.000217	0.000823	CcSEcCtD
Pergolide—Euphoric mood—Prednisone—chronic obstructive pulmonary disease	0.000215	0.000815	CcSEcCtD
Pergolide—Oedema—Salbutamol—chronic obstructive pulmonary disease	0.000214	0.000812	CcSEcCtD
Pergolide—Infection—Salbutamol—chronic obstructive pulmonary disease	0.000213	0.000806	CcSEcCtD
Pergolide—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.000212	0.000803	CcSEcCtD
Pergolide—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.000212	0.000803	CcSEcCtD
Pergolide—Pancreatitis—Prednisolone—chronic obstructive pulmonary disease	0.000212	0.000803	CcSEcCtD
Pergolide—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000211	0.000799	CcSEcCtD
Pergolide—Shock—Salbutamol—chronic obstructive pulmonary disease	0.00021	0.000799	CcSEcCtD
Pergolide—Thrombophlebitis—Prednisone—chronic obstructive pulmonary disease	0.00021	0.000795	CcSEcCtD
Pergolide—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.000209	0.000792	CcSEcCtD
Pergolide—Diabetes mellitus—Prednisone—chronic obstructive pulmonary disease	0.000209	0.000791	CcSEcCtD
Pergolide—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.000207	0.000785	CcSEcCtD
Pergolide—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.000206	0.000783	CcSEcCtD
Pergolide—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000206	0.000783	CcSEcCtD
Pergolide—HTR2A—trachea—chronic obstructive pulmonary disease	0.000206	0.0187	CbGeAlD
Pergolide—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.000205	0.000778	CcSEcCtD
Pergolide—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.000205	0.000778	CcSEcCtD
Pergolide—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.000204	0.000774	CcSEcCtD
Pergolide—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000204	0.000773	CcSEcCtD
Pergolide—Vascular purpura—Prednisone—chronic obstructive pulmonary disease	0.000203	0.000769	CcSEcCtD
Pergolide—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.000202	0.000767	CcSEcCtD
Pergolide—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.000202	0.000766	CcSEcCtD
Pergolide—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.000202	0.000766	CcSEcCtD
Pergolide—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.000201	0.000764	CcSEcCtD
Pergolide—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.000201	0.000764	CcSEcCtD
Pergolide—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.000201	0.000762	CcSEcCtD
Pergolide—Cardiac failure congestive—Prednisone—chronic obstructive pulmonary disease	0.0002	0.000759	CcSEcCtD
Pergolide—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.0002	0.000758	CcSEcCtD
Pergolide—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.000199	0.000757	CcSEcCtD
Pergolide—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.000199	0.000757	CcSEcCtD
Pergolide—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.000199	0.000756	CcSEcCtD
Pergolide—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000199	0.000754	CcSEcCtD
Pergolide—Injury—Prednisone—chronic obstructive pulmonary disease	0.000197	0.000749	CcSEcCtD
Pergolide—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.000197	0.000749	CcSEcCtD
Pergolide—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000197	0.000747	CcSEcCtD
Pergolide—Weight increased—Prednisolone—chronic obstructive pulmonary disease	0.000196	0.000745	CcSEcCtD
Pergolide—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.000195	0.000741	CcSEcCtD
Pergolide—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000195	0.00074	CcSEcCtD
Pergolide—Constipation—Formoterol—chronic obstructive pulmonary disease	0.000194	0.000735	CcSEcCtD
Pergolide—Pain—Arformoterol—chronic obstructive pulmonary disease	0.000194	0.000735	CcSEcCtD
Pergolide—Pain—Formoterol—chronic obstructive pulmonary disease	0.000194	0.000735	CcSEcCtD
Pergolide—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.000194	0.000735	CcSEcCtD
Pergolide—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.000194	0.000734	CcSEcCtD
Pergolide—Increased appetite—Prednisone—chronic obstructive pulmonary disease	0.000193	0.000733	CcSEcCtD
Pergolide—Amnesia—Prednisone—chronic obstructive pulmonary disease	0.000193	0.000733	CcSEcCtD
Pergolide—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.000192	0.000729	CcSEcCtD
Pergolide—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.000191	0.000724	CcSEcCtD
Pergolide—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.00019	0.000722	CcSEcCtD
Pergolide—Pain—Montelukast—chronic obstructive pulmonary disease	0.00019	0.00072	CcSEcCtD
Pergolide—Acute coronary syndrome—Prednisolone—chronic obstructive pulmonary disease	0.00019	0.00072	CcSEcCtD
Pergolide—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000189	0.000718	CcSEcCtD
Pergolide—Myocardial infarction—Prednisolone—chronic obstructive pulmonary disease	0.000189	0.000716	CcSEcCtD
Pergolide—Neuropathy peripheral—Prednisolone—chronic obstructive pulmonary disease	0.000189	0.000716	CcSEcCtD
Pergolide—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.000188	0.000715	CcSEcCtD
Pergolide—Purpura—Prednisone—chronic obstructive pulmonary disease	0.000188	0.000714	CcSEcCtD
Pergolide—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000188	0.000712	CcSEcCtD
Pergolide—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000188	0.000712	CcSEcCtD
Pergolide—Conjunctivitis—Prednisolone—chronic obstructive pulmonary disease	0.000187	0.00071	CcSEcCtD
Pergolide—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.000187	0.000708	CcSEcCtD
Pergolide—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.000187	0.000708	CcSEcCtD
Pergolide—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000187	0.000708	CcSEcCtD
Pergolide—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.000186	0.000706	CcSEcCtD
Pergolide—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000186	0.000704	CcSEcCtD
Pergolide—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.000185	0.000703	CcSEcCtD
Pergolide—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.000185	0.000703	CcSEcCtD
Pergolide—Pain—Salbutamol—chronic obstructive pulmonary disease	0.000183	0.000694	CcSEcCtD
Pergolide—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.000183	0.000694	CcSEcCtD
Pergolide—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.000181	0.000689	CcSEcCtD
Pergolide—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.000179	0.00068	CcSEcCtD
Pergolide—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.000179	0.00068	CcSEcCtD
Pergolide—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.000179	0.00068	CcSEcCtD
Pergolide—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.000179	0.00068	CcSEcCtD
Pergolide—Affect lability—Prednisone—chronic obstructive pulmonary disease	0.000179	0.000678	CcSEcCtD
Pergolide—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000179	0.000677	CcSEcCtD
Pergolide—Psychotic disorder—Prednisone—chronic obstructive pulmonary disease	0.000177	0.000672	CcSEcCtD
Pergolide—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000177	0.000672	CcSEcCtD
Pergolide—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000177	0.000671	CcSEcCtD
Pergolide—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000177	0.000671	CcSEcCtD
Pergolide—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.000176	0.000669	CcSEcCtD
Pergolide—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000176	0.000667	CcSEcCtD
Pergolide—Bradycardia—Prednisolone—chronic obstructive pulmonary disease	0.000176	0.000667	CcSEcCtD
Pergolide—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.000175	0.000666	CcSEcCtD
Pergolide—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.000175	0.000666	CcSEcCtD
Pergolide—Face oedema—Prednisone—chronic obstructive pulmonary disease	0.000175	0.000665	CcSEcCtD
Pergolide—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.000175	0.000664	CcSEcCtD
Pergolide—ADRA2A—lung—chronic obstructive pulmonary disease	0.000174	0.0158	CbGeAlD
Pergolide—Cardiac arrest—Prednisone—chronic obstructive pulmonary disease	0.000173	0.000655	CcSEcCtD
Pergolide—Mood swings—Prednisone—chronic obstructive pulmonary disease	0.000172	0.000652	CcSEcCtD
Pergolide—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.000169	0.000642	CcSEcCtD
Pergolide—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.000169	0.000642	CcSEcCtD
Pergolide—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000167	0.000633	CcSEcCtD
Pergolide—Visual impairment—Prednisolone—chronic obstructive pulmonary disease	0.000166	0.000631	CcSEcCtD
Pergolide—Dry skin—Prednisone—chronic obstructive pulmonary disease	0.000166	0.000631	CcSEcCtD
Pergolide—Hypokalaemia—Prednisone—chronic obstructive pulmonary disease	0.000165	0.000626	CcSEcCtD
Pergolide—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000163	0.000617	CcSEcCtD
Pergolide—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000163	0.000617	CcSEcCtD
Pergolide—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.00016	0.000608	CcSEcCtD
Pergolide—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.00016	0.000608	CcSEcCtD
Pergolide—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000159	0.000604	CcSEcCtD
Pergolide—Abdominal distension—Prednisone—chronic obstructive pulmonary disease	0.000158	0.000599	CcSEcCtD
Pergolide—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.000157	0.000596	CcSEcCtD
Pergolide—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000155	0.000588	CcSEcCtD
Pergolide—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000155	0.000588	CcSEcCtD
Pergolide—Arrhythmia—Prednisolone—chronic obstructive pulmonary disease	0.000154	0.000585	CcSEcCtD
Pergolide—Pancreatitis—Prednisone—chronic obstructive pulmonary disease	0.000154	0.000583	CcSEcCtD
Pergolide—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000154	0.000582	CcSEcCtD
Pergolide—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000152	0.000576	CcSEcCtD
Pergolide—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000151	0.000574	CcSEcCtD
Pergolide—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.00015	0.000568	CcSEcCtD
Pergolide—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.00015	0.000568	CcSEcCtD
Pergolide—HTR2A—lung—chronic obstructive pulmonary disease	0.000148	0.0135	CbGeAlD
Pergolide—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000147	0.000557	CcSEcCtD
Pergolide—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000146	0.000555	CcSEcCtD
Pergolide—Erectile dysfunction—Prednisone—chronic obstructive pulmonary disease	0.000144	0.000548	CcSEcCtD
Pergolide—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000144	0.000547	CcSEcCtD
Pergolide—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000144	0.000547	CcSEcCtD
Pergolide—Rash—Formoterol—chronic obstructive pulmonary disease	0.000143	0.000542	CcSEcCtD
Pergolide—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000143	0.000542	CcSEcCtD
Pergolide—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000143	0.000542	CcSEcCtD
Pergolide—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000143	0.000542	CcSEcCtD
Pergolide—Weight increased—Prednisone—chronic obstructive pulmonary disease	0.000143	0.000541	CcSEcCtD
Pergolide—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000142	0.000539	CcSEcCtD
Pergolide—Headache—Formoterol—chronic obstructive pulmonary disease	0.000142	0.000539	CcSEcCtD
Pergolide—Weight decreased—Prednisone—chronic obstructive pulmonary disease	0.000142	0.000538	CcSEcCtD
Pergolide—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000141	0.000537	CcSEcCtD
Pergolide—Hyperglycaemia—Prednisone—chronic obstructive pulmonary disease	0.000141	0.000537	CcSEcCtD
Pergolide—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000141	0.000535	CcSEcCtD
Pergolide—Rash—Montelukast—chronic obstructive pulmonary disease	0.00014	0.000531	CcSEcCtD
Pergolide—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.00014	0.00053	CcSEcCtD
Pergolide—Ill-defined disorder—Prednisolone—chronic obstructive pulmonary disease	0.00014	0.000529	CcSEcCtD
Pergolide—Depression—Prednisone—chronic obstructive pulmonary disease	0.000139	0.000529	CcSEcCtD
Pergolide—Headache—Montelukast—chronic obstructive pulmonary disease	0.000139	0.000527	CcSEcCtD
Pergolide—Acute coronary syndrome—Prednisone—chronic obstructive pulmonary disease	0.000138	0.000523	CcSEcCtD
Pergolide—Neuropathy peripheral—Prednisone—chronic obstructive pulmonary disease	0.000137	0.00052	CcSEcCtD
Pergolide—Myocardial infarction—Prednisone—chronic obstructive pulmonary disease	0.000137	0.00052	CcSEcCtD
Pergolide—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000136	0.000516	CcSEcCtD
Pergolide—Malaise—Prednisolone—chronic obstructive pulmonary disease	0.000136	0.000514	CcSEcCtD
Pergolide—Vertigo—Prednisolone—chronic obstructive pulmonary disease	0.000135	0.000513	CcSEcCtD
Pergolide—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000135	0.000512	CcSEcCtD
Pergolide—Syncope—Prednisolone—chronic obstructive pulmonary disease	0.000135	0.000512	CcSEcCtD
Pergolide—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000135	0.000511	CcSEcCtD
Pergolide—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000135	0.000511	CcSEcCtD
Pergolide—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000135	0.000511	CcSEcCtD
Pergolide—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000134	0.000508	CcSEcCtD
Pergolide—Loss of consciousness—Prednisolone—chronic obstructive pulmonary disease	0.000132	0.000501	CcSEcCtD
Pergolide—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000132	0.0005	CcSEcCtD
Pergolide—Convulsion—Prednisolone—chronic obstructive pulmonary disease	0.00013	0.000494	CcSEcCtD
Pergolide—Hypertension—Prednisolone—chronic obstructive pulmonary disease	0.00013	0.000492	CcSEcCtD
Pergolide—Bradycardia—Prednisone—chronic obstructive pulmonary disease	0.000128	0.000485	CcSEcCtD
Pergolide—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000127	0.000482	CcSEcCtD
Pergolide—Discomfort—Prednisolone—chronic obstructive pulmonary disease	0.000126	0.00048	CcSEcCtD
Pergolide—Hallucination—Prednisone—chronic obstructive pulmonary disease	0.000125	0.000474	CcSEcCtD
Pergolide—Oedema—Prednisolone—chronic obstructive pulmonary disease	0.000123	0.000466	CcSEcCtD
Pergolide—Shock—Prednisolone—chronic obstructive pulmonary disease	0.000121	0.000458	CcSEcCtD
Pergolide—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	0.00012	0.000454	CcSEcCtD
Pergolide—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	0.000119	0.00045	CcSEcCtD
Pergolide—Eye disorder—Prednisone—chronic obstructive pulmonary disease	0.000117	0.000445	CcSEcCtD
Pergolide—Arrhythmia—Prednisone—chronic obstructive pulmonary disease	0.000112	0.000425	CcSEcCtD
Pergolide—Insomnia—Prednisolone—chronic obstructive pulmonary disease	0.000111	0.000421	CcSEcCtD
Pergolide—Alopecia—Prednisone—chronic obstructive pulmonary disease	0.000111	0.000421	CcSEcCtD
Pergolide—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	0.00011	0.000418	CcSEcCtD
Pergolide—Pain—Prednisolone—chronic obstructive pulmonary disease	0.000105	0.000398	CcSEcCtD
Pergolide—Ill-defined disorder—Prednisone—chronic obstructive pulmonary disease	0.000101	0.000385	CcSEcCtD
Pergolide—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	0.000101	0.000384	CcSEcCtD
Pergolide—Anaemia—Prednisone—chronic obstructive pulmonary disease	0.000101	0.000383	CcSEcCtD
Pergolide—Agitation—Prednisone—chronic obstructive pulmonary disease	0.0001	0.000381	CcSEcCtD
Pergolide—Malaise—Prednisone—chronic obstructive pulmonary disease	9.85e-05	0.000374	CcSEcCtD
Pergolide—Vertigo—Prednisone—chronic obstructive pulmonary disease	9.82e-05	0.000372	CcSEcCtD
Pergolide—Syncope—Prednisone—chronic obstructive pulmonary disease	9.8e-05	0.000372	CcSEcCtD
Pergolide—Loss of consciousness—Prednisone—chronic obstructive pulmonary disease	9.6e-05	0.000364	CcSEcCtD
Pergolide—Convulsion—Prednisone—chronic obstructive pulmonary disease	9.47e-05	0.000359	CcSEcCtD
Pergolide—Hypertension—Prednisone—chronic obstructive pulmonary disease	9.43e-05	0.000358	CcSEcCtD
Pergolide—Arthralgia—Prednisone—chronic obstructive pulmonary disease	9.3e-05	0.000353	CcSEcCtD
Pergolide—Myalgia—Prednisone—chronic obstructive pulmonary disease	9.3e-05	0.000353	CcSEcCtD
Pergolide—Anxiety—Prednisone—chronic obstructive pulmonary disease	9.27e-05	0.000352	CcSEcCtD
Pergolide—Discomfort—Prednisone—chronic obstructive pulmonary disease	9.19e-05	0.000349	CcSEcCtD
Pergolide—Oedema—Prednisone—chronic obstructive pulmonary disease	8.92e-05	0.000338	CcSEcCtD
Pergolide—Infection—Prednisone—chronic obstructive pulmonary disease	8.86e-05	0.000336	CcSEcCtD
Pergolide—Shock—Prednisone—chronic obstructive pulmonary disease	8.77e-05	0.000333	CcSEcCtD
Pergolide—Tachycardia—Prednisone—chronic obstructive pulmonary disease	8.7e-05	0.00033	CcSEcCtD
Pergolide—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	8.62e-05	0.000327	CcSEcCtD
Pergolide—Anorexia—Prednisone—chronic obstructive pulmonary disease	8.5e-05	0.000322	CcSEcCtD
Pergolide—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	8.12e-05	0.000308	CcSEcCtD
Pergolide—Dizziness—Prednisolone—chronic obstructive pulmonary disease	8.11e-05	0.000308	CcSEcCtD
Pergolide—Insomnia—Prednisone—chronic obstructive pulmonary disease	8.07e-05	0.000306	CcSEcCtD
Pergolide—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	8.01e-05	0.000304	CcSEcCtD
Pergolide—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	7.85e-05	0.000298	CcSEcCtD
Pergolide—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	7.75e-05	0.000294	CcSEcCtD
Pergolide—Rash—Prednisolone—chronic obstructive pulmonary disease	7.74e-05	0.000294	CcSEcCtD
Pergolide—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	7.73e-05	0.000293	CcSEcCtD
Pergolide—Headache—Prednisolone—chronic obstructive pulmonary disease	7.69e-05	0.000292	CcSEcCtD
Pergolide—Constipation—Prednisone—chronic obstructive pulmonary disease	7.63e-05	0.000289	CcSEcCtD
Pergolide—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	7.35e-05	0.000279	CcSEcCtD
Pergolide—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	7.29e-05	0.000277	CcSEcCtD
Pergolide—Nausea—Prednisolone—chronic obstructive pulmonary disease	7.29e-05	0.000277	CcSEcCtD
Pergolide—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	7.05e-05	0.000267	CcSEcCtD
Pergolide—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	7.05e-05	0.000267	CcSEcCtD
Pergolide—Asthenia—Prednisone—chronic obstructive pulmonary disease	6.4e-05	0.000243	CcSEcCtD
Pergolide—Pruritus—Prednisone—chronic obstructive pulmonary disease	6.31e-05	0.000239	CcSEcCtD
Pergolide—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	6.1e-05	0.000231	CcSEcCtD
Pergolide—Dizziness—Prednisone—chronic obstructive pulmonary disease	5.9e-05	0.000224	CcSEcCtD
Pergolide—Vomiting—Prednisone—chronic obstructive pulmonary disease	5.67e-05	0.000215	CcSEcCtD
Pergolide—Rash—Prednisone—chronic obstructive pulmonary disease	5.62e-05	0.000213	CcSEcCtD
Pergolide—Dermatitis—Prednisone—chronic obstructive pulmonary disease	5.62e-05	0.000213	CcSEcCtD
Pergolide—Headache—Prednisone—chronic obstructive pulmonary disease	5.59e-05	0.000212	CcSEcCtD
Pergolide—Nausea—Prednisone—chronic obstructive pulmonary disease	5.3e-05	0.000201	CcSEcCtD
Pergolide—ADRA2A—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.29e-05	0.000117	CbGpPWpGaD
Pergolide—HTR1A—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	1.27e-05	0.000116	CbGpPWpGaD
Pergolide—HTR2C—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	1.27e-05	0.000115	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	1.26e-05	0.000115	CbGpPWpGaD
Pergolide—ADRA2B—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	1.26e-05	0.000114	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	1.26e-05	0.000114	CbGpPWpGaD
Pergolide—DRD5—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	1.25e-05	0.000114	CbGpPWpGaD
Pergolide—HTR1D—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	1.25e-05	0.000113	CbGpPWpGaD
Pergolide—ADRA2C—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	1.23e-05	0.000112	CbGpPWpGaD
Pergolide—DRD2—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	1.23e-05	0.000112	CbGpPWpGaD
Pergolide—ADRA2A—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.22e-05	0.000111	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	1.22e-05	0.000111	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	1.22e-05	0.000111	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	1.22e-05	0.000111	CbGpPWpGaD
Pergolide—HTR1B—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	1.22e-05	0.000111	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	1.22e-05	0.00011	CbGpPWpGaD
Pergolide—ADRA1B—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	1.21e-05	0.00011	CbGpPWpGaD
Pergolide—HTR2A—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	1.21e-05	0.00011	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	1.21e-05	0.00011	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	1.2e-05	0.000109	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	1.2e-05	0.000109	CbGpPWpGaD
Pergolide—DRD4—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	1.2e-05	0.000109	CbGpPWpGaD
Pergolide—CYP2D6—Metabolism—CTGF—chronic obstructive pulmonary disease	1.19e-05	0.000108	CbGpPWpGaD
Pergolide—DRD5—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	1.19e-05	0.000108	CbGpPWpGaD
Pergolide—HTR1D—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	1.19e-05	0.000108	CbGpPWpGaD
Pergolide—ADRA1A—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	1.18e-05	0.000108	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	1.18e-05	0.000107	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	1.18e-05	0.000107	CbGpPWpGaD
Pergolide—ADRA2B—Signaling Pathways—LEP—chronic obstructive pulmonary disease	1.17e-05	0.000106	CbGpPWpGaD
Pergolide—HTR1B—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	1.16e-05	0.000106	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	1.16e-05	0.000105	CbGpPWpGaD
Pergolide—HTR2B—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	1.15e-05	0.000104	CbGpPWpGaD
Pergolide—DRD4—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	1.15e-05	0.000104	CbGpPWpGaD
Pergolide—HTR1D—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	1.14e-05	0.000103	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—LEP—chronic obstructive pulmonary disease	1.13e-05	0.000103	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—LEP—chronic obstructive pulmonary disease	1.12e-05	0.000102	CbGpPWpGaD
Pergolide—DRD2—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	1.12e-05	0.000101	CbGpPWpGaD
Pergolide—HTR1B—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	1.11e-05	0.000101	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	1.11e-05	0.000101	CbGpPWpGaD
Pergolide—ADRA2A—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	1.1e-05	0.0001	CbGpPWpGaD
Pergolide—HTR2A—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	1.1e-05	9.98e-05	CbGpPWpGaD
Pergolide—CYP2D6—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.1e-05	9.98e-05	CbGpPWpGaD
Pergolide—DRD4—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	1.09e-05	9.94e-05	CbGpPWpGaD
Pergolide—HTR2B—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	1.09e-05	9.94e-05	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—LEP—chronic obstructive pulmonary disease	1.09e-05	9.94e-05	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	1.09e-05	9.93e-05	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	1.09e-05	9.92e-05	CbGpPWpGaD
Pergolide—DRD1—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	1.08e-05	9.82e-05	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—LEP—chronic obstructive pulmonary disease	1.08e-05	9.78e-05	CbGpPWpGaD
Pergolide—ADRA1A—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	1.08e-05	9.77e-05	CbGpPWpGaD
Pergolide—ADRA2A—Hemostasis—TP53—chronic obstructive pulmonary disease	1.07e-05	9.71e-05	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	1.07e-05	9.71e-05	CbGpPWpGaD
Pergolide—DRD5—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	1.07e-05	9.7e-05	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	1.07e-05	9.7e-05	CbGpPWpGaD
Pergolide—ADRA1D—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	1.07e-05	9.69e-05	CbGpPWpGaD
Pergolide—DRD3—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	1.07e-05	9.69e-05	CbGpPWpGaD
Pergolide—HTR2B—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	1.04e-05	9.49e-05	CbGpPWpGaD
Pergolide—DRD1—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	1.03e-05	9.37e-05	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	1.03e-05	9.35e-05	CbGpPWpGaD
Pergolide—ADRA2C—Metabolism—ALB—chronic obstructive pulmonary disease	1.02e-05	9.31e-05	CbGpPWpGaD
Pergolide—ADRA1D—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	1.02e-05	9.25e-05	CbGpPWpGaD
Pergolide—DRD3—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	1.02e-05	9.25e-05	CbGpPWpGaD
Pergolide—HTR1D—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	1.01e-05	9.15e-05	CbGpPWpGaD
Pergolide—ADRA2A—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	1e-05	9.08e-05	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	9.93e-06	9.02e-05	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—LEP—chronic obstructive pulmonary disease	9.93e-06	9.02e-05	CbGpPWpGaD
Pergolide—HTR1B—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	9.86e-06	8.96e-05	CbGpPWpGaD
Pergolide—DRD1—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	9.85e-06	8.95e-05	CbGpPWpGaD
Pergolide—DRD5—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	9.8e-06	8.91e-05	CbGpPWpGaD
Pergolide—ADRA2C—Metabolism—NOS3—chronic obstructive pulmonary disease	9.8e-06	8.9e-05	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—LEP—chronic obstructive pulmonary disease	9.77e-06	8.87e-05	CbGpPWpGaD
Pergolide—ADRA1D—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	9.72e-06	8.83e-05	CbGpPWpGaD
Pergolide—DRD3—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	9.72e-06	8.83e-05	CbGpPWpGaD
Pergolide—DRD4—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	9.71e-06	8.82e-05	CbGpPWpGaD
Pergolide—ADRA2B—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	9.63e-06	8.75e-05	CbGpPWpGaD
Pergolide—DRD5—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	9.61e-06	8.73e-05	CbGpPWpGaD
Pergolide—HTR1D—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	9.58e-06	8.7e-05	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—LEP—chronic obstructive pulmonary disease	9.57e-06	8.69e-05	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	9.56e-06	8.68e-05	CbGpPWpGaD
Pergolide—HTR1B—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	9.38e-06	8.52e-05	CbGpPWpGaD
Pergolide—HTR1A—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	9.3e-06	8.45e-05	CbGpPWpGaD
Pergolide—HTR2B—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	9.27e-06	8.42e-05	CbGpPWpGaD
Pergolide—HTR2C—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	9.25e-06	8.4e-05	CbGpPWpGaD
Pergolide—DRD4—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	9.23e-06	8.38e-05	CbGpPWpGaD
Pergolide—ADRA2B—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	9.19e-06	8.35e-05	CbGpPWpGaD
Pergolide—CYP2D6—Metabolism—GSTP1—chronic obstructive pulmonary disease	9.16e-06	8.32e-05	CbGpPWpGaD
Pergolide—HTR1D—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	9.11e-06	8.28e-05	CbGpPWpGaD
Pergolide—CYP2D6—Metabolism—HMOX1—chronic obstructive pulmonary disease	9.03e-06	8.21e-05	CbGpPWpGaD
Pergolide—ADRA2C—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	9e-06	8.17e-05	CbGpPWpGaD
Pergolide—HTR1B—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	8.92e-06	8.1e-05	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—LEP—chronic obstructive pulmonary disease	8.89e-06	8.07e-05	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	8.87e-06	8.06e-05	CbGpPWpGaD
Pergolide—ADRA1B—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	8.85e-06	8.04e-05	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	8.83e-06	8.02e-05	CbGpPWpGaD
Pergolide—HTR2B—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	8.81e-06	8e-05	CbGpPWpGaD
Pergolide—DRD4—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	8.78e-06	7.98e-05	CbGpPWpGaD
Pergolide—ADRA2B—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	8.78e-06	7.97e-05	CbGpPWpGaD
Pergolide—DRD1—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	8.74e-06	7.94e-05	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	8.64e-06	7.85e-05	CbGpPWpGaD
Pergolide—ADRA1D—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	8.62e-06	7.83e-05	CbGpPWpGaD
Pergolide—DRD3—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	8.62e-06	7.83e-05	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	8.59e-06	7.8e-05	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	8.54e-06	7.76e-05	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	8.47e-06	7.7e-05	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	8.45e-06	7.68e-05	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	8.43e-06	7.66e-05	CbGpPWpGaD
Pergolide—CYP2D6—Metabolism—GSTM1—chronic obstructive pulmonary disease	8.42e-06	7.65e-05	CbGpPWpGaD
Pergolide—HTR2B—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	8.38e-06	7.61e-05	CbGpPWpGaD
Pergolide—ADRA2A—Metabolism—ALB—chronic obstructive pulmonary disease	8.32e-06	7.56e-05	CbGpPWpGaD
Pergolide—DRD1—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	8.31e-06	7.55e-05	CbGpPWpGaD
Pergolide—DRD3—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	8.2e-06	7.45e-05	CbGpPWpGaD
Pergolide—ADRA1D—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	8.2e-06	7.45e-05	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	8.2e-06	7.45e-05	CbGpPWpGaD
Pergolide—HTR1D—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	8.18e-06	7.43e-05	CbGpPWpGaD
Pergolide—DRD2—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	8.16e-06	7.42e-05	CbGpPWpGaD
Pergolide—DRD5—Signaling Pathways—TP53—chronic obstructive pulmonary disease	8.07e-06	7.33e-05	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	8.07e-06	7.33e-05	CbGpPWpGaD
Pergolide—HTR2A—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	8.03e-06	7.3e-05	CbGpPWpGaD
Pergolide—HTR1B—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	8.01e-06	7.28e-05	CbGpPWpGaD
Pergolide—CYP2D6—Metabolism—CYP1A1—chronic obstructive pulmonary disease	7.98e-06	7.25e-05	CbGpPWpGaD
Pergolide—ADRA2A—Metabolism—NOS3—chronic obstructive pulmonary disease	7.96e-06	7.23e-05	CbGpPWpGaD
Pergolide—DRD1—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	7.9e-06	7.18e-05	CbGpPWpGaD
Pergolide—DRD4—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	7.88e-06	7.16e-05	CbGpPWpGaD
Pergolide—ADRA1A—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	7.86e-06	7.14e-05	CbGpPWpGaD
Pergolide—ADRA1D—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	7.8e-06	7.08e-05	CbGpPWpGaD
Pergolide—DRD3—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	7.8e-06	7.08e-05	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	7.79e-06	7.08e-05	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	7.79e-06	7.08e-05	CbGpPWpGaD
Pergolide—ADRA2B—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	7.78e-06	7.07e-05	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	7.67e-06	6.96e-05	CbGpPWpGaD
Pergolide—HTR2B—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	7.53e-06	6.84e-05	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	7.51e-06	6.83e-05	CbGpPWpGaD
Pergolide—HTR1D—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	7.51e-06	6.82e-05	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	7.51e-06	6.82e-05	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	7.48e-06	6.79e-05	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	7.44e-06	6.76e-05	CbGpPWpGaD
Pergolide—ADRA2B—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	7.4e-06	6.72e-05	CbGpPWpGaD
Pergolide—DRD5—Signaling Pathways—IL6—chronic obstructive pulmonary disease	7.39e-06	6.71e-05	CbGpPWpGaD
Pergolide—HTR1D—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	7.36e-06	6.69e-05	CbGpPWpGaD
Pergolide—HTR1B—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	7.35e-06	6.68e-05	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	7.32e-06	6.65e-05	CbGpPWpGaD
Pergolide—ADRA2A—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	7.31e-06	6.64e-05	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	7.27e-06	6.6e-05	CbGpPWpGaD
Pergolide—DRD4—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	7.24e-06	6.57e-05	CbGpPWpGaD
Pergolide—HTR1B—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	7.21e-06	6.55e-05	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	7.18e-06	6.52e-05	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	7.17e-06	6.51e-05	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	7.16e-06	6.5e-05	CbGpPWpGaD
Pergolide—HTR1A—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	7.15e-06	6.49e-05	CbGpPWpGaD
Pergolide—HTR2C—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	7.11e-06	6.46e-05	CbGpPWpGaD
Pergolide—DRD1—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	7.1e-06	6.45e-05	CbGpPWpGaD
Pergolide—DRD4—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	7.09e-06	6.44e-05	CbGpPWpGaD
Pergolide—ADRA2B—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	7.04e-06	6.4e-05	CbGpPWpGaD
Pergolide—DRD3—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	7e-06	6.36e-05	CbGpPWpGaD
Pergolide—ADRA1D—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	7e-06	6.36e-05	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	6.97e-06	6.33e-05	CbGpPWpGaD
Pergolide—ADRA2C—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	6.91e-06	6.28e-05	CbGpPWpGaD
Pergolide—HTR2B—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	6.91e-06	6.27e-05	CbGpPWpGaD
Pergolide—ADRA1B—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	6.8e-06	6.18e-05	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	6.8e-06	6.17e-05	CbGpPWpGaD
Pergolide—HTR2B—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	6.77e-06	6.15e-05	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	6.76e-06	6.14e-05	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	6.66e-06	6.05e-05	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	6.6e-06	5.99e-05	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	6.58e-06	5.97e-05	CbGpPWpGaD
Pergolide—DRD1—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	6.51e-06	5.92e-05	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	6.49e-06	5.9e-05	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	6.47e-06	5.88e-05	CbGpPWpGaD
Pergolide—ADRA1D—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	6.43e-06	5.84e-05	CbGpPWpGaD
Pergolide—DRD3—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	6.43e-06	5.84e-05	CbGpPWpGaD
Pergolide—DRD1—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	6.39e-06	5.8e-05	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	6.36e-06	5.77e-05	CbGpPWpGaD
Pergolide—ADRA2B—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	6.32e-06	5.74e-05	CbGpPWpGaD
Pergolide—ADRA1D—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	6.3e-06	5.72e-05	CbGpPWpGaD
Pergolide—DRD3—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	6.3e-06	5.72e-05	CbGpPWpGaD
Pergolide—DRD2—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	6.27e-06	5.7e-05	CbGpPWpGaD
Pergolide—HTR1D—Signaling Pathways—TP53—chronic obstructive pulmonary disease	6.18e-06	5.62e-05	CbGpPWpGaD
Pergolide—HTR2A—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	6.17e-06	5.61e-05	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	6.1e-06	5.54e-05	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	6.07e-06	5.52e-05	CbGpPWpGaD
Pergolide—HTR1B—Signaling Pathways—TP53—chronic obstructive pulmonary disease	6.05e-06	5.5e-05	CbGpPWpGaD
Pergolide—ADRA1A—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	6.04e-06	5.49e-05	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	5.99e-06	5.44e-05	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	5.97e-06	5.42e-05	CbGpPWpGaD
Pergolide—DRD4—Signaling Pathways—TP53—chronic obstructive pulmonary disease	5.96e-06	5.41e-05	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	5.91e-06	5.37e-05	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	5.91e-06	5.36e-05	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	5.91e-06	5.36e-05	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	5.87e-06	5.33e-05	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	5.81e-06	5.28e-05	CbGpPWpGaD
Pergolide—ADRA2B—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	5.8e-06	5.27e-05	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	5.75e-06	5.22e-05	CbGpPWpGaD
Pergolide—ADRA2B—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	5.69e-06	5.17e-05	CbGpPWpGaD
Pergolide—HTR2B—Signaling Pathways—TP53—chronic obstructive pulmonary disease	5.69e-06	5.17e-05	CbGpPWpGaD
Pergolide—HTR1D—Signaling Pathways—IL6—chronic obstructive pulmonary disease	5.66e-06	5.14e-05	CbGpPWpGaD
Pergolide—ADRA2A—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	5.62e-06	5.1e-05	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	5.6e-06	5.09e-05	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	5.57e-06	5.06e-05	CbGpPWpGaD
Pergolide—HTR1B—Signaling Pathways—IL6—chronic obstructive pulmonary disease	5.54e-06	5.03e-05	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	5.5e-06	5e-05	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	5.49e-06	4.99e-05	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	5.46e-06	4.96e-05	CbGpPWpGaD
Pergolide—DRD4—Signaling Pathways—IL6—chronic obstructive pulmonary disease	5.45e-06	4.95e-05	CbGpPWpGaD
Pergolide—CYP2D6—Metabolism—ALB—chronic obstructive pulmonary disease	5.42e-06	4.93e-05	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	5.42e-06	4.92e-05	CbGpPWpGaD
Pergolide—DRD1—Signaling Pathways—TP53—chronic obstructive pulmonary disease	5.36e-06	4.87e-05	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	5.36e-06	4.87e-05	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	5.34e-06	4.85e-05	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	5.33e-06	4.85e-05	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	5.31e-06	4.83e-05	CbGpPWpGaD
Pergolide—ADRA1D—Signaling Pathways—TP53—chronic obstructive pulmonary disease	5.29e-06	4.81e-05	CbGpPWpGaD
Pergolide—DRD3—Signaling Pathways—TP53—chronic obstructive pulmonary disease	5.29e-06	4.81e-05	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	5.27e-06	4.79e-05	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	5.23e-06	4.75e-05	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	5.22e-06	4.74e-05	CbGpPWpGaD
Pergolide—HTR2B—Signaling Pathways—IL6—chronic obstructive pulmonary disease	5.21e-06	4.73e-05	CbGpPWpGaD
Pergolide—CYP2D6—Metabolism—NOS3—chronic obstructive pulmonary disease	5.19e-06	4.71e-05	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	5.16e-06	4.69e-05	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	4.92e-06	4.47e-05	CbGpPWpGaD
Pergolide—DRD1—Signaling Pathways—IL6—chronic obstructive pulmonary disease	4.91e-06	4.46e-05	CbGpPWpGaD
Pergolide—ADRA1D—Signaling Pathways—IL6—chronic obstructive pulmonary disease	4.84e-06	4.4e-05	CbGpPWpGaD
Pergolide—DRD3—Signaling Pathways—IL6—chronic obstructive pulmonary disease	4.84e-06	4.4e-05	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	4.84e-06	4.4e-05	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	4.82e-06	4.38e-05	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	4.8e-06	4.36e-05	CbGpPWpGaD
Pergolide—ADRA2B—Signaling Pathways—TP53—chronic obstructive pulmonary disease	4.78e-06	4.34e-05	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	4.74e-06	4.31e-05	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	4.74e-06	4.3e-05	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	4.65e-06	4.22e-05	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—TP53—chronic obstructive pulmonary disease	4.61e-06	4.19e-05	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—TP53—chronic obstructive pulmonary disease	4.59e-06	4.17e-05	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—TP53—chronic obstructive pulmonary disease	4.46e-06	4.05e-05	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	4.4e-06	4e-05	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—TP53—chronic obstructive pulmonary disease	4.39e-06	3.99e-05	CbGpPWpGaD
Pergolide—ADRA2B—Signaling Pathways—IL6—chronic obstructive pulmonary disease	4.37e-06	3.97e-05	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	4.32e-06	3.92e-05	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—IL6—chronic obstructive pulmonary disease	4.22e-06	3.83e-05	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—IL6—chronic obstructive pulmonary disease	4.2e-06	3.81e-05	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—IL6—chronic obstructive pulmonary disease	4.08e-06	3.71e-05	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—TP53—chronic obstructive pulmonary disease	4.05e-06	3.68e-05	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—IL6—chronic obstructive pulmonary disease	4.02e-06	3.65e-05	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—TP53—chronic obstructive pulmonary disease	3.98e-06	3.62e-05	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—TP53—chronic obstructive pulmonary disease	3.9e-06	3.54e-05	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—IL6—chronic obstructive pulmonary disease	3.71e-06	3.37e-05	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—IL6—chronic obstructive pulmonary disease	3.65e-06	3.31e-05	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—TP53—chronic obstructive pulmonary disease	3.62e-06	3.29e-05	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—IL6—chronic obstructive pulmonary disease	3.57e-06	3.24e-05	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	3.55e-06	3.22e-05	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	3.39e-06	3.08e-05	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—IL6—chronic obstructive pulmonary disease	3.32e-06	3.01e-05	CbGpPWpGaD
